Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Payables (2020 - 2025)

Historic Payables for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to $7.7 million.

  • Stemtech's Payables rose 5571.01% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 5571.01%. This contributed to the annual value of $6.6 million for FY2024, which is 6463.54% up from last year.
  • Latest data reveals that Stemtech reported Payables of $7.7 million as of Q3 2025, which was up 5571.01% from $7.6 million recorded in Q2 2025.
  • Stemtech's 5-year Payables high stood at $7.7 million for Q3 2025, and its period low was $2.8 million during Q3 2022.
  • In the last 5 years, Stemtech's Payables had a median value of $5.3 million in 2021 and averaged $5.2 million.
  • As far as peak fluctuations go, Stemtech's Payables crashed by 2785.08% in 2022, and later skyrocketed by 6463.54% in 2024.
  • Stemtech's Payables (Quarter) stood at $5.3 million in 2021, then dropped by 27.85% to $3.8 million in 2022, then grew by 3.76% to $4.0 million in 2023, then soared by 64.64% to $6.6 million in 2024, then grew by 17.35% to $7.7 million in 2025.
  • Its last three reported values are $7.7 million in Q3 2025, $7.6 million for Q2 2025, and $7.3 million during Q1 2025.